Cancer Risk Assessment for the Primary Care Physician
Section snippets
Family history assessment
Family history is a known risk factor for a multitude of chronic diseases, including cardiovascular disease, diabetes, and cancer; thus, obtaining a family history of medical illness is a recognized and important component of primary care assessment. From the standpoint of cancer risk assessment, a thorough family history should include all of the following components:
- ■
Ethnic background of each grandparent.
- ■
Information about maternal and paternal relatives.
- ■
Information on at least first-degree
Hereditary breast and ovarian cancer
It is estimated that 5% to 10% of breast cancers occur in women with an inherited susceptibility to cancer.13 Most of these are women with hereditary breast and ovarian cancer syndrome (HBOC), which is explained by deleterious mutations in the BRCA1 and BRCA2 genes, although several less common genetic disorders, such as Li-Fraumeni syndrome, Cowden syndrome, and Peutz-Jeghers syndrome also include a predisposition to breast cancer.12 These syndromes exhibit autosomal dominant inheritance.
Hereditary colon cancer
Approximately 20% of individuals diagnosed with colon cancer have a strong family history (2 or more first- or second-degree relatives), and about 3% to 5% of colon cancers occur in the context of genetically defined high-risk syndromes.27 The two most common of these are hereditary nonpolyposis colorectal cancer (HNPCC or Lynch syndrome) and familial adenomatous polyposis (FAP), which are inherited in an autosomal dominant fashion.
HNPCC-associated cancers result from mutations in one of
Familial prostate cancer
Familial clustering of prostate cancer has been well described, but to date no specific high-penetrance susceptibility genes have been identified, and thus clinical genetic testing is not currently available. Several candidate genetic loci have been identified in linkage analyses and, more recently, in genome-wide association studies.32 However, the preponderance of data suggests that the genetic basis of prostate cancer is incredibly complex, and this is an area of active research.
Family
Familial melanoma
It is estimated that 5% to 7% of melanoma patients are from genetically at-risk families. Familial melanoma is generally defined by the presence of 3 or more affected blood relatives in families located in regions of intense sun exposure or 2 or more affected family members in areas with less intense sun exposure. Individuals with an inherited predisposition to melanoma are prone to early-onset disease (mean age at diagnosis is 34 years) and tend to develop multiple primary melanomas.36
Cancer risk assessment models
Statistical models for cancer risk prediction fall into 2 broad categories: those that are used to predict the probability of being diagnosed with a particular cancer, and those that predict the likelihood of carrying a gene mutation that predisposes to a particular cancer or set of cancers. Several commonly used risk assessment models for common cancers are described in the following sections.
Modifiable cancer risk factors
It is believed that cancer may be a fundamentally preventable disease; as many as 90% to 95% of all cancers are attributed to potentially modifiable behavioral and environmental risk factors.53 Most important among these factors are tobacco, alcohol consumption, and obesity. Thus, by assessing and influencing lifestyle factors during primary care visits, the physician may have a considerable effect on cancer incidence and patient outcomes.
Summary
Primary care physicians are uniquely situated to identify individuals at increased genetic or environmental risk of cancer. The early identification of a suspected heritable cancer syndrome can lead to additional evaluation and to interventions that can substantially decrease cancer risk. Web-based tools for collecting and summarizing family history information and for predicting individual risks for certain cancers and familial syndromes are easily accessible and are available for use by the
References (86)
- et al.
Family history-taking in community family practice: implications for genetic screening
Genet Med
(2000) - et al.
Molecular evidence linking primary cancer of the fallopian tube to BRCA1 germline mutations
Gynecol Oncol
(2000) Genetic testing for high-risk colon cancer patients
Gastroenterology
(2003)- et al.
New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC
Gastroenterology
(1999) - et al.
Are physicians asking about tobacco use and assisting with cessation? Results from the 2001–2004 national ambulatory medical care survey (NAMCS)
Prev Med
(2006) - et al.
Epidemiology and prevention of oral cancer
Oral Oncol
(1997) - et al.
American College of Preventive Medicine Practice Policy statement. Weight management counseling of overweight adults
Am J Prev Med
(2001) - et al.
Self-reported nutrition proficiency is positively correlated with the perceived quality of nutrition training of family physicians in Washington State
Am J Clin Nutr
(2003) - et al.
Physical activity and cancer prevention: etiologic evidence and biological mechanisms
J Nutr
(2002) - et al.
A controlled trial of physician counseling to promote the adoption of physical activity
Prev Med
(1996)
The effect of physician advice on exercise behavior
Prev Med
Cancer statistics, 2008
CA Cancer J Clin
Reconsidering the family history in primary care
J Gen Intern Med
GPs' views on their role in cancer genetics services and current practice
Fam Pract
The ‘new genetics’ and primary care: GPs' views on their role and their educational needs
Fam Pract
Genetic/familial high risk assessment: breast and ovarian
Breast cancer screening and diagnosis guidelines
Colorectal cancer screening
Screening for prostate cancer: an update of the evidence for the U.S. Preventive Services Task Force
Ann Intern Med
Counseling and DNA testing for individuals perceived to be genetically predisposed to melanoma: a consensus statement of the Melanoma Genetics Consortium
J Clin Oncol
Concise handbook of familial cancer susceptibility syndromes - second edition
J Natl Cancer Inst Monogr
Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease
Lancet
The Breast Cancer Linkage Consortium. Cancer risks in BRCA2 mutation carriers
J Natl Cancer Inst
American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography
CA Cancer J Clin
NIH consensus conference. Ovarian cancer. Screening, treatment, and follow-up. NIH Consensus Development Panel on Ovarian Cancer
JAMA
Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers
J Natl Cancer Inst
Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group
J Clin Oncol
Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers
J Clin Oncol
Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation
N Engl J Med
Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations
N Engl J Med
Prophylactic oophorectomy reduces breast cancer penetrance during prospective, long-term follow-up of BRCA1 mutation carriers
J Clin Oncol
Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
J Natl Cancer Inst
Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial
JAMA
Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial
JAMA
A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer
Cancer Res
Cancer risk in mutation carriers of DNA-mismatch-repair genes
Int J Cancer
Hereditary colorectal cancer
N Engl J Med
Hereditary colorectal cancer syndromes: molecular genetics, genetic counseling, diagnosis and management
Fam Cancer
Prostate cancer susceptibility loci: finding the genes
Adv Exp Med Biol
Empiric risk of prostate carcinoma for relatives of patients with prostate carcinoma: a meta-analysis
Cancer
The role of the BRCA2 gene in susceptibility to prostate cancer revisited
Cancer Epidemiol Biomarkers Prev
Five-alpha-reductase Inhibitors for prostate cancer prevention
Cochrane Database Syst Rev
Cited by (7)
Colorectal Cancer – An Update for Primary Care Nurse Practitioners
2018, Journal for Nurse PractitionersCitation Excerpt :Non-modifiable risk factors include age, family history, ethnicity, and a personal history of a predisposing genetic syndrome or inflammatory bowel disease. Modifiable risk factors include lack of physical exercise, a diet low in fruits, vegetables, and fiber and high in fat, red meat, and processed meat, smoking, drinking alcohol, and being overweight or obese.10,20,21 Published literature has shown an association for each of those risk factors, but not always conclusive evidence.
The evaluation of the educational plan of breast self-examination of women referring to health centers
2012, Procedia - Social and Behavioral SciencesEvaluation of the awareness of childhood cancers by general practitioners, family physicians and pediatricians
2020, Marmara Medical JournalExploring the cancer risk perception and interest in genetic services among Indigenous people in Queensland, Australia
2014, Australian and New Zealand Journal of Public Health